French Observatory of Acute Heart Failure (OFICA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01080937|
Recruitment Status : Completed
First Posted : March 5, 2010
Last Update Posted : November 24, 2017
During the last decade, progress has been made in the management of heart failure. However, the changing characteristics of patients and practices in the "real world" and their impact on the prognosis of patients admitted for acute heart failure remain poorly studied.
2000 consecutive patients recruited in a single day in hospitals volunteered to participate in the cohort during a day dedicated.
|Condition or disease|
|Acute Heart Failure|
The total duration of recruitment is one day (date to be set soon by the Executive Committee): all patients hospitalized, and whatever their date of admission with the diagnosis of heart failure will be selected for the study.
Information on each hospital stay will be obtained at baseline and at the end of the hospitalization by the hospital teams.
A telephone follow-up will be conducted at 3 months among survivors and / or their doctor by CRAs dedicated to the French Society of Cardiology.
|Study Type :||Observational|
|Actual Enrollment :||1818 participants|
|Official Title:||French Observatory of Acute Heart Failure|
|Study Start Date :||March 2009|
|Actual Primary Completion Date :||December 2010|
|Actual Study Completion Date :||February 2011|
Patient with acute heart failure
Hospitalized patient, whatever the mode of initial admission with acute heart failure
- Survival at 3 months [ Time Frame: 3 months ]Analyze survival 3 months after the end of initial hospitalization
- Hospital Methods [ Time Frame: 3 months ]Compare methods of care based on clinical characteristics and hospital structures.
- Patterns of admission [ Time Frame: 3 months ]Analyze patterns of admission and discharge of patients, depending on their characteristics
- Co-morbidities [ Time Frame: 3 months ]Analyze the co-morbidities and their impact on care and survival
- Drug treatments [ Time Frame: 3 months ]Analyze the evolution of drug treatment between the output and monitoring to 3 months
- Resources specific diagnostic [ Time Frame: 3 months ]Analyze the use of resources specific diagnostic: measurement of BNP or NTproBNP, conducting echocardiogram, coronary angiography, Holter-ECG, Cardiac MRI, Cardiac CT
- Therapeutic resources [ Time Frame: 3 months ]Analyze the use of therapeutic resources based on specific clinical features: intensive care, ventilation, inotropes, ultrafiltration, introduction of beta-blockers, stimulation, implantable cardioverter defibrillator, circulatory support, graft
- During of stay [ Time Frame: 3 months ]Analyze the duration of stay according to clinical characteristics.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01080937
|Paris, France, 75010|
|Principal Investigator:||Damien DL LOGEART||French Cardiology Society|